ROCKWELL MEDICAL, INC. Quarterly Depreciation in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Rockwell Medical, Inc. quarterly/annual Depreciation history and growth rate from Q2 2017 to Q3 2024.
  • Rockwell Medical, Inc. Depreciation for the quarter ending September 30, 2024 was $400K, unchanged year-over-year.
  • Rockwell Medical, Inc. Depreciation for the twelve months ending September 30, 2024 was $1.6M, a 45.5% increase year-over-year.
  • Rockwell Medical, Inc. annual Depreciation for 2023 was $1.2M, a 100% increase from 2022.
  • Rockwell Medical, Inc. annual Depreciation for 2022 was $600K, a 10.2% decline from 2021.
  • Rockwell Medical, Inc. annual Depreciation for 2021 was $668K, a 19.9% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.6M $400K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.6M $400K +$200K +100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.4M $400K +$200K +100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.2M $400K +$100K +33.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $1.1M $400K +$300K +300% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $800K $200K +$100K +100% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $700K $200K +$100K +100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $600K $300K +$132K +78.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $468K $100K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $468K $100K -$100K -50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $568K $100K -$100K -50% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $668K $168K +$134K +394% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $534K $100K -$100K -50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $634K $200K -$200K -50% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $834K $200K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $834K $34K -$154K -81.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-08
Q3 2020 $988K $200K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $988K $400K +$200K +100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $788K $200K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $788K $188K +$38.2K +25.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $750K $200K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $750K $200K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $750K $200K +$100K +100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $650K $150K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 $200K +$74.2K +58.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $200K +$71.2K +55.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $100K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $126K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $129K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.